Clin2
NCT06693362Worth exploringRecruiting

Stem cell therapy for severe viral pneumonia

Severe Viral Pneumonia(Not Include COVID-19)

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This trial tests whether injecting stem cells from the womb's blood supply can help treat severe viral pneumonia. It aims to improve recovery for people who are very sick and need hospital care.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
60 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You are between 18 and 85 years old.
  • You have severe pneumonia caused by a virus (other than COVID-19) that requires hospital care.
  • You do not have any active cancer or pre-cancerous conditions.
  • You are not currently on a heart-lung bypass machine (ECMO).
  • You are not taking strong immune-suppressing drugs like high-dose steroids or chemotherapy.
  • You are not pregnant, breastfeeding, and agree to use effective birth control during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07413978Recruiting· Phase 1/Phase 2
Stem cell injection for severe ARDS

This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).

Wuhan, Hubei
NCT05842382Recruiting· Phase 2
High-dose IV vitamin C for severe pneumonia

This trial tests whether high-dose vitamin C given through an IV can improve outcomes in people with severe pneumonia. It may help your body fight infection and reduce complications, but it also has several safety checks.

Alor Star, Kedah
NCT07338123Not yet recruiting· Early Phase 1
Combined therapy for severe pneumonia from resistant bacteria

This trial tests whether adding a Chinese herbal formula (Yiqi Huoxue Jiedu) and inhaled bacteriophages (viruses that kill bacteria) to standard care can help treat severe pneumonia caused by drug-resistant bacteria like Klebsiella, Acinetobacter, or Pseudomonas. It is for adults aged 18 to 85 who are not pregnant or immunocompromised and can undergo a bronchoscopy to collect samples.

NCT07612605Not yet recruiting· Early Phase 1
Chinese herbal medicine and bacteriophages for severe resistant pneumonia

This early-stage trial tests a combination of a traditional Chinese herbal formula and bacteriophages (viruses that kill bacteria) to treat severe pneumonia caused by drug-resistant bacteria. The treatment is inhaled directly into the lungs and may help when standard antibiotics don't work.

Guangdong, Guangzhou
NCT07351500Not yet recruiting· Phase 3
Testing steroids for severe flu pneumonia in adults

This study tests if giving steroids can help adults with severe pneumonia caused by the flu who are in the ICU. You may qualify if you are very sick with flu pneumonia and need a breathing tube or other intensive treatments.

NCT05017298Not yet recruiting· Phase 2
Stem cell treatment for severe or critical COVID-19

This trial tests donated (allogeneic) fat-derived stem cells to see if they improve outcomes in adults with severe or critical COVID-19. It may help calm severe lung/immune problems, but whether it works and is safe will be studied in this Phase 2 study.

Hear when a new Severe Viral Pneumonia(Not Include COVID-19) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.